NCU Research Grants Awarded 2018

 

Principal investigator Project Title Project workplace (principal investigator) Awarded amount (Euros)
Ahti Anttila Comparing cervical cancer screening in the Nordic countries: Transition from cytology to HPV testing Finnish Cancer Registry/ Cancer Society of Finland 40.000
Anders Pærregaard The incidence of cancer and mortality in paediatric onset inflammatory bowel disease - A population-based multicentre study from Denmark and Finland Copenhagen University 30.000
Asgeir Store Jakola A novel use of an old drug to treat brain tumors Department of Neurosurgery, Sahlgrenska University Hospital 50.000
Björn Nilsson Genetic predisposition for multiple myeloma: clinical impact of recently identified risk variants Lund University 50.000
Eero Pukkala New wave of joint Nordic studies on work and cancer Finnish Cancer Registry 50.000
Håkan Jonsson Estimation of Overdiagnosis in Breast Cancer Screening Umeå University 50.000
Jana de Boniface Survival and axillary recurrence after sentinel node-positive breast cancer without axillary lymph node dissection: the randomized controlled SENOMAC trial. Karolinska Institutet 65.000
Jesper Lagergren Antireflux surgery and cancer risk in the Nordic Antireflux Surgery Cohort (NordASCo) Karolinska Institutet 50.000
Jiong Li Maternal diseases during pregnancy and childhood leukemia in the offspring: a cohort study in 8 million children in five Nordic countries Department of Clinical Epidemiology, Aarhus University  40.000
Karin Smedby Life after Lymphoma - how can we individualize treatment and care to reduce complications and improve lymphoma survivorship in the Nordic countries Karolinska Institutet 30.000
Kim Sverker Pettersson NANOPARTICLE AIDED GLYCOVARIANT BIOMARKERS FOR THE EARLY DETECTION OF EPITHELIAL OVARIAN CANCER (2nd year application) University of Turku 60.000
Mats Jerkeman Mantle cell lymphoma - a comprehensive Nordic initiative to improve patient outcome Lund University 50.000
Olof Akre SPCG-15: SURGERY VERSUS RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: A RANDOMIZED CLINICAL TRIAL Karolinska University Hospital 50.000
Satu Mustjoki Immunological monitoring of therapy response in chronic myeloid leukemia by the Nordic CML study group (NCMLSG) University of Helsinki 65.000
Sirpa Leppä Precision medicine in aggressive B-cell lymphomas Helsinki University Hospital Comprehensive Cancer Centre/University of Helsinki with Nordic Lymphoma Group Large B-Cell working group 30.000
Ulf Gunnarsson MSI in sporadic colorectal cancer: register data and tissue analyses regarding cancer in other organs, clinical presentation and immune response. Umeå University 40.000
Total 750.000

 

NCU Research Grants Awarded 2017

 

Principal investigator Project Title Project workplace (principal investigator) Awarded amount (Euros)
Abildgaard, Niels  Magnolia Study. Prolonged Protection from Bone Disease in Multiple Myeloma. An open label phase 3 multi-center Nordic randomised trial. Odense University Hospital, Department of Haematology. 40.000
Akre, Olof SPCG-15: Surgery versus radiotherapy for locally advanced prostate cancer: a randomized clinical trial  Karollinska Institutet 50.000
de Boniface, Jana Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial Dept. of Surgery, Capio St Göran's Hospital, and Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 30.000
Engholm, Gerda NORDCAN development. Differences in cancer survival in the Nordic countries: the role of stage at presentation, treatment, comorbidity and education Danish Cancer Society 50.000
Grønberg, Bjørn H. A Randomized Phase II Study Comparing Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer Norwegian University of Science and Technology and St. Olavs hospital, Trondheim University Hospital 40.000
Gunnarsson, Ulf MSI in sporadic colorectal cancer: register data regarding cancer in other organs, clinical presentation and immune response Umeå University, Department of Surgical and Perioperative Sciences  40.000
Harris, Jennifer Genetic Epidemiology and Familial Risk of Cross-Cancer Associations: A Nordic Twin Study-II The Norwegian Institute of Public Health 40.000
Hellström Lindberg, Eva Nordic Collaborative Clinical Database Initiative and Allogeneic Stem Cell Transplantation Project for Myelodysplastic Syndromes Department of Medicine, Karolinska Institutet, Karolinska University Hospital 40.000
Jakola, Asgeir S.  Disulfiram response as add-on to chemotherapy in recurrent glioblastoma  Sahlgrenska University Hospital and St.Olavs Hospital 40.000
Johansen, Christoffer Late effects in Nordic cancer patients - LECA Rigshospitalet and the Danish Cancer Society Research Center 50.000
Jonsson, Håkan Estimation of Overdiagnosis in Breast Cancer Screening Umeå Univerity 40.000
Kristinsson, Sigurdur Yngvi Comorbidity and multiple myeloma University of Iceland 30.000
Lagergren, Jesper Antireflux surgery and cancer risk in the Nordic Antireflux Surgery Cohort (NordASCo) Karolinska Institutet 40.000
Lindman, Henrik Nordic TRIP – a randomized phase-3 trial of adjuvant and neoadjuvant treatment in early triple negative breast cancer Onkologiska Kliniken, Akademiska Sjukhuset, Uppsala 30.000
Murtola, Teemu Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy – lipid metabolism as a novel biomarker to predict prostate cancer progression – phase 3, double-blind randomized clinical trial University of Tampere, Faculty of Medicine and Life Sciences 40.000
Pettersson, Kim Nanoparticle aided glycovariant  biomarkers for the early detection of epithelial ovarian cancer Department of Biochemistry, Division of Biotechnology, University of Turku 30.000
Pukkala, Eero New wave of joint Nordic studies on work and cancer Finnish Cancer Registry / University of Tampere 40.000
Rodriguez-Wallberg, Kenny Alexandra An investigation of GnRHa exposure in connection with cancer treatment: Effects on fecundity, cancer recurrence and death  Karolinska Institutet and Karolinska University Hospital 40.000
Tryggvadóttir, Laufey Prognostic Factors, Treatment and Breast Cancer Survival in Nordic BRCA2 Mutation Carriers University of Iceland, Icelandic Cancer Society 40.000
Total 750.000

 

NCU Research Grants Awarded 2016

 

 

Principal Investigator

Project Title

Project workplace
(Principal Investigator)

 

Awarded amount  (Euros)    

  Akre. Olof

 SPCG-15: Surgery versus radiotherapy for locally advanced prostate cancer: a rando+C2:C19mized clinical trial

 Karolinska Institutet, Sweden

50.000

 Bill-Axelson, Anna

 SPCG-17: Prostate Cancer Active Surveillance Trigger Trial (PCASTT)

Uppsala University, Akademiska Hospital, Sweden

65.000

 Brown - for the Nordic Lymphoma Group, Peter de Nully

 Clinical trial-based precision medicine in the Nordic countries for patients with aggressive lymphomas

Rigshospitalet, Denmark

40.000

 Giwercman, Aleksander

 The impact of testicular cancer and its treatment on the health of the offspring

Dept. of Translational Medicine, Lund University, Sweden

40.000

 Grønberg, Bjørn H.

 A Randomized Phase II Study Comparing Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer

Norwegian University of Science and Technology and St. Olavs Hospital - Trondheim University Hospital, Norway

65.000

 Harris, Jennifer

 Genetic Epidemiology and Familial Risk of Cross-Cancer Associations: A Nordic Twin Study

The Norwegian Institute of Public Health, Norway

40.000

 Hellström Lindberg, Eva

 Nordic Collaborative Clinical Database Initative and Allogeneic Stem Cell Transplantation Project for Myelodysplastic Syndromes

Karolinska Institutet, Dept of Medicine, Karolinska University Hospital, Sweden

40.000

 Jakola, Asgeir S.

 Disulfiram response as add-on to chemotherapy in recurrent glioblastoma: A randomized controlled trial

Sahlgrenska and St.Olavs Hospital, Norway

40.000

 Jonsson, Håkan

 Estimation of overdiagnosis in breast cancer screening

Umeå Univerity, Sweden

50.000

 Li, Jiong

 Maternal diseases during pregnancy and childhood leukemia in the offspring: a cohort study in 8 million children in five Nordic countries

Aarhus University, Denmark

50.000

 Pasternak, Björn

 Cancer risk associated with new glucose-lowering drugs: a joint register-based cohort study in Sweden, Denmark, and Norway

Karolinska Institutet, Sweden

65.000

 Lagergren, Jesper

 Antireflux surgery and cancer risk in the Nordic Antireflux Surgery Cohort (NordASCo)

Karolinska Institutet, Sweden

40.000

 Lynge, Elsebeth

 Impact of screening on cancer incidence trends and age-patterns

University of Copenhagen, Denmark

50.000

 Stocks Charles, Tanja

 Metabolic traits, tobacco smoking, and bladder cancer risk; a study on biological interactions in relation to low- and high-risk disease

Lund University, Sweden

40.000

 Tryggvadóttir, Laufey

 Prognostic Factors, Treatment and Breast Cancer Survival in Nordic BRCA2 Mutation Carriers

University of Iceland and Icelandic Cancer Registry, Skogarhlid 8, Iceland

50.000

 Valberg, Morten

 Improved estimation of familial cancer risks: Utilizing modern statistical methods

Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway

25.000

 Total

 

 

750.000